Second line chemotherapy in metastatic non-small cell lung cancer
Moro-Sibilot, D.; Coudurier, M.
La Revue du Praticien 59(7): 952-953
2009
ISSN/ISBN: 0035-2640 PMID: 19839464 Document Number: 637173
Document emailed within 1 workday
Related Documents
Moro-Sibilot, D.; Coudurier, M. 2009: Targeted therapies in second line treatment of metastatic non-small cell lung cancer La Revue du Praticien 59(7): 955-956Thongprasert, S.; Cheewakriangkrai, R.; Napapan, S. 2002: Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer Journal of the Medical Association of Thailand 85(12): 1296-1300
Cucević, B.; Samarzija, M.; Baricević, D.; Jakopović, M.; Redzepi, G.; Samija, M. 2005: Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer Collegium Antropologicum 29(2): 583-588
Ishiura, Y.; Yamamoto, H.; Terasaki, Y.; Ishida, Y.; Tohge, M.; Segawa, M.; Kusajima, Y.; Saitoh, K.; Ishikawa, M.; Hirokami, N.; Kasahara, K.; Fujimura, M. 2011: Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2631-2633
Lissoni, P.; Messina, G.; Balestra, A.; Colciago, M.; Brivio, F.; Fumagalli, L.; Fumagalli, G.; Parolini, D. 2008: Efficacy of cancer chemotherapy in relation to synchronization of cortisol rhythm, immune status and psychospiritual profile in metastatic non-small cell lung cancer In Vivo 22(2): 257-262
Ciuleanu, T.E.; Curcă, R.; Iancu, D.; Todor, N.; Cebotaru, C.; Radulescu, I.; Banu, E.; Ghilezan, N. 2002: First-line chemotherapy with topotecan and etoposide in advanced small cell lung cancer. a phase Ii study Journal of Buon: Official Journal of the Balkan Union of Oncology 7(1): 43-46
Li, F.; Chen, G.; Jiao, S. 2015: Bevacizumab Combined with Chemotherapy as First-line Therapy for Advanced Non-Small Cell Lung Cancer: A Retrospective Study Hepato-Gastroenterology 62(140): 797-801
Abou-Mourad, Y.; Otrock, Z.K.; Makarem, J.A.; Kattan, J.G.; Farhat, F.S.; Jalloul, R.; Mokaddem, W.T.; Ghosen, M.G.; Taher, A.T.; Chehal, A.A.; Shamseddine, A.I. 2008: Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study Le Journal Medical Libanais. Lebanese Medical Journal 56(1): 16-21
Mencoboni, M.; Bergaglio, M.; Serra, M.; Ivaldi, G.P.; Tredici, S.; Racchi, O.; Rebella, L.; Galbusera, V.; Grosso, M.; Faravelli, B. 2007: Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer Anticancer Research 27(6c): 4425-4429
Khuri, F.R. 2002: Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy Oncology 16(6 Suppl 6: 53-62
Cortesi, E.; Nelli, F. 2004: Chemotherapy in the treatment of advanced metastatic non-small cell carcinoma of the lung I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(2): S52-S55
Lin, J.C.; Cheng, J.Y.; Meng, C.L. 1992: An animal model for colon cancer metastases to the lung and establishment of metastatic cancer cell line Journal of the Formosan Medical Association 91(Suppl 1): S34-S38
Williams, C.J.; Woods, R.; Levi, J.; Page, J. 1988: Chemotherapy for non-small cell lung cancer: a randomized trial of cisplatin/vindesine v no chemotherapy Seminars in Oncology 15(6 Suppl 7: 58-61
Xiao, Y.-Y.; Zhan, P.; Yuan, D.-M.; Liu, H.-B.; Lv, T.-F.; Shi, Y.; Song, Y. 2013: Chemotherapy plus Vandetanib or chemotherapy alone in advanced non-small cell lung cancer: a meta-analysis of four randomised controlled trials Clinical Oncology 25(1): E7
Aapro, M.S. 1997: Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer Oncology 11(8 Suppl 8: 46-49
Momozane, T.; Higashiyama, M.; Maeda, J.; Okami, J.; Oda, K.; Imamura, F.; Yoneda, K.; Takenaka, A.; Kodama, K. 2009: Surgical treatment for the second double lung cancers following chemotherapy for small cell lung cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 62(2): 117-121
Mirski, S.E.; Evans, C.D.; Almquist, K.C.; Slovak, M.L.; Cole, S.P. 1993: Altered topoisomerase Ii alpha in a drug-resistant small cell lung cancer cell line selected in VP-16 Cancer Research 53(20): 4866-4873
Ying Geng, Z.; Chang Jiao, S.; Cui Liu, S.; Li, Y.; Feng Liu, Z.; Qing Zhang, G.; Jie Wang, L.; Qu, F. 2013: Third-line therapy in advanced non-small cell lung cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 18(4): 899-907
Evans, W.K.; Shepherd, F.A.; Feld, R.; Osoba, D.; DeBoer, G. 1986: First-line therapy with VP-16 and cisplatin for small-cell lung cancer Seminars in Oncology 13(3 Suppl 3: 17-23
Maneechawakajorn, J.; Suksuperm, J. 2014: Quality of life in advanced non-small cell lung cancer receiving chemotherapy of platinum combination in old versus new standard chemotherapy regimen Journal of the Medical Association of Thailand 97(Suppl 11): S69-S75